Get the Stockscreener App
48.73
1.10%
-0.54
After Hours:
48.73
Legend Biotech Corp Adr stock is traded at $48.73, with a volume of 1.14M.
It is down -1.10% in the last 24 hours and down -15.33% over the past month.
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
See More
Previous Close:
$49.27
Open:
$50.93
24h Volume:
1.14M
Relative Volume:
1.22
Market Cap:
$8.90B
Revenue:
$455.99M
Net Income/Loss:
$-285.01M
P/E Ratio:
-14.95
EPS:
-3.26
Net Cash Flow:
$-164.61M
1W Performance:
+6.12%
1M Performance:
-15.33%
6M Performance:
-13.12%
1Y Performance:
-27.45%
1-Day Range:
$48.05
$51.43
1-Week Range:
$43.13
$51.43
52-Week Range:
$38.60
$70.78
Legend Biotech Corp Adr Stock (LEGN) Company Profile
Name
Legend Biotech Corp Adr
Sector
Industry
Phone
-
Address
-
Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-23 | Initiated | Scotiabank | Sector Perform |
| Nov-06-23 | Initiated | Goldman | Buy |
| May-25-23 | Initiated | William Blair | Mkt Perform |
| May-22-23 | Initiated | Daiwa Securities | Buy |
| Mar-29-23 | Initiated | H.C. Wainwright | Buy |
| Mar-24-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-06-22 | Initiated | UBS | Buy |
| Nov-02-22 | Initiated | Evercore ISI | Outperform |
| Nov-01-22 | Initiated | Cowen | Outperform |
| Oct-31-22 | Initiated | Guggenheim | Neutral |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Mar-15-22 | Initiated | Barclays | Overweight |
| Jan-31-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-06-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-21-21 | Initiated | Piper Sandler | Overweight |
| May-18-21 | Initiated | BTIG Research | Buy |
| Jul-01-20 | Initiated | JP Morgan | Overweight |
| Jul-01-20 | Initiated | Jefferies | Buy |
| Jun-30-20 | Initiated | Morgan Stanley | Overweight |
View All
Legend Biotech Corp Adr Stock (LEGN) Latest News
Legend Biotech Corp ADR (LEGN) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Can you now get a good deal on Legend Biotech Corp ADR’s shares? - US Post News
There is no doubt that Legend Biotech Corp ADR (LEGN) ticks all the boxes. - SETE News
Closing Bell Recap: Legend Biotech Corp ADR (LEGN) Ends at 45.92, Reflecting a -5.38 Downturn - The Dwinnex
Analytical Lens: Exploring Legend Biotech Corp ADR (LEGN)’s Financial Story Through Ratios - The Dwinnex
What was Legend Biotech Corp ADR (LEGN)’s performance in the last session? - US Post News
European Investors Can Invest in the Future of U.S. Healthcare With This ETF - Trackinsight
Legend Biotech Corp ADR (LEGN) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Financial Analysis: Legend Biotech Corp ADR (LEGN)’s Ratios Unveil Key Insights - The Dwinnex
This trade activity should not be overlooked: Legend Biotech Corp ADR (LEGN) - SETE News
Legend Biotech Corp ADR (LEGN)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Legend Biotech Corp ADR (LEGN) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Is Central Puerto (CEPU) Stock Outpacing Its Oils-Energy Peers This Year? - Yahoo Finance
Earnings Estimates Rising for Atour Lifestyle Holdings Limited Sponsored ADR (ATAT): Will It Gain? - Yahoo Finance
Wall Street Analysts Believe Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Could Rally 47.49%: Here's is How to Trade - Yahoo Finance
Hello Group Inc. Sponsored ADR (MOMO) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Chevron Corp (CVX): A Good 52-Week Low Stock to Buy Now According to Short Sellers - Yahoo Finance
Gene Therapy Market Size to Reach USD 54.39 Billion By 2032 with CAGR of 23.12%, Boosted by Rising Genetic Disorders and Advances in CRISPR Technology - GlobeNewswire Inc.
Best Income Stocks to Buy for August 30th - Yahoo Finance
Here's Why Brainsway Ltd. Sponsored ADR (BWAY) is a Great Momentum Stock to Buy - Yahoo Finance
NIO Inc. (NIO): Top ADR Stock According to Hedge Funds - Yahoo Finance
Legend Biotech shares hold Buy rating on China approval - Investing.com India
Legend Biotech shares hold Buy rating on China approval - Investing.com
Company News for Aug 27, 2024 - Yahoo Finance
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Bentley Systems, Incorporated (NASDAQ:BSY) Shares Bought by Blue Trust Inc. - Defense World
Blue Trust Inc. Raises Stake in TD SYNNEX Co. (NYSE:SNX) - Defense World
Blue Trust Inc. Increases Holdings in Corpay, Inc. (NYSE:CPAY) - Defense World
Blue Trust Inc. Has $38,000 Holdings in Sasol Limited (NYSE:SSL) - Defense World
Blue Trust Inc. Raises Stock Holdings in Colliers International Group Inc. (NASDAQ:CIGI) - Defense World
Blue Trust Inc. Purchases New Position in Kingsoft Cloud Holdings Limited (NASDAQ:KC) - Defense World
Blue Trust Inc. Increases Stake in Cousins Properties Incorporated (NYSE:CUZ) - Defense World
Blue Trust Inc. Grows Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) - Defense World
Blue Trust Inc. Increases Stock Position in EQT Co. (NYSE:EQT) - Defense World
Blue Trust Inc. Buys 4,019 Shares of Centrais Elétricas Brasileiras S.A. – Eletrobrás (NYSE:EBR) - Defense World
Blue Trust Inc. Increases Position in OneMain Holdings, Inc. (NYSE:OMF) - Defense World
New York State Teachers Retirement System Reduces Position in Ralph Lauren Co. (NYSE:RL) - Defense World
Aurora Innovation (NASDAQ:AUR) Trading Up 11.3% - Defense World
Wealth Enhancement Advisory Services LLC Raises Position in UiPath Inc. (NYSE:PATH) - Defense World
Fifth Third Bancorp Increases Stock Position in Ralph Lauren Co. (NYSE:RL) - Defense World
MINISO Group Holding Limited Unsponsored ADR (MNSO) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Does Legend Biotech Corp ADR (LEGN) offer a good opportunity for investors? - SETE News
Li Auto Inc. Sponsored ADR (LI) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
What Makes Purple Biotech (PPBT) a New Buy Stock - Yahoo Finance
Why PDD Holdings Inc. Sponsored ADR (PDD) Outpaced the Stock Market Today - Yahoo Finance
Legend Biotech Co. (NASDAQ:LEGN) Sees Significant Drop in Short Interest - MarketBeat
HDFC Bank Limited (NYSE:HDB) Shares Bought by Vanguard Group Inc. - Defense World
3D Systems Co. (NYSE:DDD) Shares Sold by California State Teachers Retirement System - Defense World
P2P Global Investments (LON:P2P) Share Price Crosses Below 200 Day Moving Average of $826.00 - Defense World
California State Teachers Retirement System Sells 4,045 Shares of Berry Co. (NASDAQ:BRY) - Defense World
Examining Legend Biotech Corp ADR (LEGN) more closely is necessary - US Post News
Legend Biotech Corp Adr Stock (LEGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):